HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$47.38
Day range
$46.98 - $49.96
Year range
$14.63 - $52.06
Market cap
887.96M USD
Avg Volume
665.23K
P/E ratio
10.38
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 69.46M | 25.59% |
Operating expense | 28.94M | 7.00% |
Net income | 27.90M | 124.62% |
Net profit margin | 40.17 | 78.85% |
Earnings per share | 1.46 | 108.57% |
EBITDA | 29.02M | 97.88% |
Effective tax rate | -1.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.14M | 124.41% |
Total assets | 242.53M | 73.96% |
Total liabilities | 124.92M | -18.91% |
Total equity | 117.61M | — |
Shares outstanding | 18.15M | — |
Price to book | 7.31 | — |
Return on assets | 31.63% | — |
Return on capital | 44.20% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 27.90M | 124.62% |
Cash from operations | 24.03M | 10.85% |
Cash from investing | -33.18M | -972.57% |
Cash from financing | 4.27M | 143.40% |
Net change in cash | -4.87M | -131.16% |
Free cash flow | 10.05M | 46.79% |
About
Founded
1996
Headquarters
Website
Employees
163
